AP
OGN icon

Arlington Partners’s Organon & Co OGN Stock Holding History

Arlington Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4
Closed -$69 – 346
2023
Q3 		$69 Sell
4
-24
-86% -$500 ﹤0.01% 323
2023
Q2 		$583 Hold
28
– – ﹤0.01% 591
2023
Q1 		$659 Sell
28
-34
-55% -$913 ﹤0.01% 549
2022
Q4 		$1.73K Buy
62
+38
+158% +$972 ﹤0.01% 403
2022
Q3 		$1K Hold
24
– – ﹤0.01% 360
2022
Q2 		$1K Buy
+24
New +$841 ﹤0.01% 461
2022
Q1 		– Sell
-88
Closed -$3K – 594
2021
Q4 		$3K Sell
88
-65
-42% -$2.12K ﹤0.01% 617
2021
Q3 		$5K Buy
+153
New +$4.89K ﹤0.01% 367

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Arlington Partners's OGN Position: Q4 2023 in Review

Arlington Partners sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 4 shares — an estimated $69 sold.

Arlington Partners first reported a position in OGN in Q3 2021 and held it in 8 quarters. The position peaked at $5K in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Arlington Partners reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Arlington Partners sold 4 Organon & Co shares in Q4 2023, an estimated $69.
  • Arlington Partners first reported a position in Organon & Co in Q3 2021 and held it in 8 quarters.
  • Arlington Partners's Organon & Co position peaked at $5K in Q3 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Arlington Partners's 13F filing for Q4 2023, filed 24 Jan 2024.